SCHEMBL30983811

SCHEMBL30983811

CC1(Oc2ncnc3c2ncn3Cc2ccccc2)CCC1

nearest known ligand 0.66

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ DAPK1 P53355 1/20 0.62
▸ HPGD P15428 1/20 0.58
▸ ADORA2A P29274 1/20 0.53
▸ PI4KA P42356 1/20 0.53
▸ PI4K2B Q8TCG2 1/20 0.53
▸ PI4K2A Q9BTU6 1/20 0.53
▸ PI4KB Q9UBF8 1/20 0.53
▸ HRH4 Q9H3N8 1/20 0.52
▸ PDE4A P27815 1/20 0.47
▸ PDE4B Q07343 1/20 0.47
▸ PDE4C Q08493 1/20 0.47
▸ PDE4D Q08499 1/20 0.47
▸ SCN9A Q15858 1/20 0.47
▸ HTT P42858 1/20 0.46
▸ NAE1 Q13564 1/20 0.45
▸ UBA3 Q8TBC4 1/20 0.45
▸ PDE10A Q9Y233 1/20 0.43
▸ FLT4 P35916 1/20 0.43
▸ KDR P35968 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31269114 0.98 DAPK1 (0.60) DAPK1HPGDADORA2API4KAPI4K2B
SCHEMBL30983894 0.95 DAPK1 (0.65) DAPK1HPGDADORA2API4KAPI4K2B
SCHEMBL30983919 0.81 DAPK1 (0.47) DAPK1HPGDADORA2API4KAPI4K2B
9-Benzyl-6-Methoxy-9H-Purine SCHEMBL28939425 0.80 HPGD (0.77) DAPK1HPGDADORA2API4KAPI4K2B
SCHEMBL30984101 0.79 ADORA2A (0.56) ADORA2A
SCHEMBL30984102 0.79 ADORA2A (0.56) ADORA2A
Lithium SCHEMBL30983994 0.78 ADORA2A (0.55) ADORA2A
SCHEMBL17115735 0.77 DAPK1 (1.00) DAPK1HPGDADORA2API4KAPI4K2B
SCHEMBL30984045 0.77 DAPK1 (0.43) DAPK1HPGDPDE4APDE4BPDE4C
SCHEMBL30983852 0.74 MEN1 (0.42) DAPK1HPGDHRH4SCN9AHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4689155-A1 USE OF INHIBITORS TO INCREASE EFFICIENCY OF CRISPR/CAS INSERTIONS Astrazeneca AB (SE) 2026-02-11 — — EP disclosed
EP-4630410-A1 POLQ INHIBITORS Astrazeneca AB (SE) 2025-10-15 — — EP disclosed
WO-2024201368-A1 USE OF INHIBITORS TO INCREASE EFFICIENCY OF CRISPR/CAS INSERTIONS ASTRAZENECA AB (SE) 2024-10-03 — — WO disclosed
WO-2024121753-A1 POLQ INHIBITORS ASTRAZENECA AB (SE) 2024-06-13 — — WO disclosed
Send feedback